Business · 12/07/2018Updated: 10/17/2026 · 1 min read
Concordia Pharmaceuticals, Inc., et al.; Withdrawal of FDA Approval for 29 New Drug Applications
Summary
The US Food and Drug Administration (FDA) is withdrawing approval for 29 new drug applications from multiple applicants, following written notifications that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →